BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 1595206)

  • 1. [Detection of HLA-DR antigens using the ethidium bromide fluorescence test].
    Májský A
    Vnitr Lek; 1992 Feb; 38(2):173-6. PubMed ID: 1595206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of HLA-DR typing by ethidium bromide fluorescence.
    Shanahan TC; Grybel MB; Cohen E; Fritz DD; Amsterdam D
    Ann Clin Lab Sci; 1987; 17(4):236-40. PubMed ID: 3619399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HLA-DR antigen typing using the 2-color fluorescence test; the specificity and sensitivity of the method in comparison with the monocytotoxicity and B-lymphocytotoxicity tests].
    Májský A
    Vnitr Lek; 1991 Mar; 37(3):279-84. PubMed ID: 2031317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is the fluorescence cytotoxicity test for the determination of HLA-DR antigens more sensitive than the classical microcytotoxicity test?].
    Prazák J; Májský A
    Cas Lek Cesk; 1989 Aug; 128(33):1047-9. PubMed ID: 2790911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HLA antibodies in retroplacental blood samples. I. Preliminary results of a screening study].
    Rose M; Waltz H; Halle H; Henske B
    Zentralbl Gynakol; 1982; 104(20):1265-9. PubMed ID: 6760624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative fluorochromes to ethidium bromide for automated read out of cytotoxicity tests.
    Tanke HJ; van der Linden PW; Langerak J
    J Immunol Methods; 1982; 52(1):91-6. PubMed ID: 6749996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Isolation of monocytes from peripheral blood by gradient centrifugation on Lymphoprep in a hypertonic medium].
    Májský A
    Cas Lek Cesk; 1989 Dec; 128(50):1591-3. PubMed ID: 2631996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spontaneous expression of class II (HLA-DR) molecules in thyroid pathology].
    Aguayo J; Pérez MV; Trincado P; Wohllk N; Pineda G
    Rev Med Chil; 1991 Aug; 119(8):867-70. PubMed ID: 1844766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Automatic lymphocyte toxicity testing by contrast fluorescence].
    Gardell D; Rock G
    Beitr Infusionther Klin Ernahr; 1987; 18():367-8. PubMed ID: 3439994
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD24 antigen discriminates between pre-B and B cells in human bone marrow.
    Duperray C; Boiron JM; Boucheix C; Cantaloube JF; Lavabre-Bertrand T; Attal M; Brochier J; Maraninchi D; Bataille R; Klein B
    J Immunol; 1990 Dec; 145(11):3678-83. PubMed ID: 1700990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on HLA-DR typing method --micro lymphocyte cytotoxicity test (author's transl)].
    Shiwaku Y; Morita N; Shingami T; Mori H; Nakao Y; Hashimoto S
    Igaku Kenkyu; 1979 Sep; 49(3):227-35. PubMed ID: 547637
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-HLA-A, B, C and DR antibodies in renal transplant recipients.
    Akiyama N; Kusaba R; Osawa N; Inou T; Kawamura A
    Jpn J Exp Med; 1980 Jun; 50(3):205-11. PubMed ID: 7001096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Flow cytometric analysis of HLA-DR, IL-6 and IL-8 expression by conjunctival epithelial cells from patients with prolonged topical antiglaucoma treatments].
    Bensoussan L; Blondin C; Baudouin C; Hamard P; Sabeh Afaki G; Creuzot-Garcher C; Warnet JM; Brignole-Baudouin F
    J Fr Ophtalmol; 2003 Oct; 26(8):782-9. PubMed ID: 14586218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-co-ordinate expression of HLA-DR antigens and invariant chain.
    Momburg F; Möller P
    Immunology; 1988 Mar; 63(3):551-3. PubMed ID: 3280476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Attempt to use monocytes for HLA-DR typing].
    Májský A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):293-300. PubMed ID: 6194062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired antigen presentation in toxic epidermal necrolysis.
    Bagot M; Charue D; Heslan M; Wechsler J; Roujeau JC; Revuz J
    Arch Dermatol; 1993 Jun; 129(6):721-7. PubMed ID: 8507074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.
    Aichinger G; Fill H; Wick G
    Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T cells directed against HLA-DR antigens and their surface proteins.
    Burakoff SJ; Clayberger C; Hemler M; Krensky AM; Reiss CS; Robbins E; Sanchez-Madrid F; Springer TA; Strominger JL; Ware CF
    Diagn Immunol; 1983; 1(3):116-9. PubMed ID: 6238749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.